Discovery of inhibitors of the novel oncology target, Pin 1: A case study in structure guided fragment evolution

被引：0

作者：

Ray, Stuart C. ^{[1
]}

Baker, Lisa ^{[2
]}

Davis, Ben ^{[2
]}

Fromont, Christophe ^{[1
]}

Matassova, Natalia ^{[2
]}

Moore, Jon ^{[3
]}

Murray, James ^{[2
]}

Nunns, Claire ^{[1
]}

Potter, Andrew ^{[1
]}

Richardson, Christine ^{[4
]}

Robertson, Alan ^{[2
]}

Robinson, David ^{[2
]}

Simmonite, Heather ^{[2
]}

Surgenor, Allan ^{[2
]}

机构：

[1] Vernalis, Chem, Cambridge CB21 6GB, England

[2] Vernalis, Struct Sci, Cambridge CB21 6GB, England

[3] Vernalis, Oncol, Cambridge CB21 6GB, England

[4] Vernalis, Computat Chem, Cambridge CB21 6GB, England

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 238卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

61-MEDI

引用

页数：1

共 50 条

[31] Novel Fragment Inhibitors of PYCR1 from Docking-Guided X-ray Crystallography
Meeks, Kaylen R.
Ji, Juan
Protopopov, Mykola V.
Tarkhanova, Olga O.
Moroz, Yurii S.
Tanner, John J.
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, 64 (05) : 1704 - 1718
[32] Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach
Wilson, Jonathan E.
Kurukulasuriya, Ravi
Reibarkh, Mikhail
Reiter, Maud
Zwicker, Aaron
Zhao, Kake
Zhang, Fengqi
Anand, Rajan
Colandrea, Vincent J.
Cumiskey, Anne-Marie
Crespo, Alejandro
Duffy, Ruth A.
Murphy, Beth Ann
Mitra, Kaushik
Johns, Douglas G.
Duffy, Joseph L.
Vachal, Petr
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (03): : 261 - 265
[33] The discovery of Mcl-1 inhibitors using fragment-based methods and structure-based design
Fesik, Stephen W.
CANCER RESEARCH, 2016, 76
[34] Discovery of novel inhibitors of phosphodiesterase 4 with 1-phenyl-3,4-dihydroisoquinoline scaffold: Structure-based drug design and fragment identification
Liao, Yixian
Jia, Xiuhua
Tang, Yongmei
Li, Sumei
Zang, Yipeng
Wang, Lei
Cui, Zi-Ning
Song, Gaopeng
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (22)
[35] Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors
Ma, Guixing
Wang, Sanshan
Wu, Kebin
Zhang, Weizhe
Ahmad, Ashfaq
Hao, Quan
Lei, Xiaoguang
Zhang, Hongmin
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 29
[36] Structure-guided discovery of thiazolidine-2,4-dione derivatives as a novel class of Leishmania major pteridine reductase 1 inhibitors
Leite, Franco Henrique A.
Gomes da Silva Santiago, Priscila Brandao
Froes, Thamires Quadros
da Silva Filho, Joao
da Silva, Suellen Goncalves
Ximenes, Rafael M.
de Faria, Antonio Rodolfo
Brondani, Dalci Jose
de Albuquerque, Julianna F. C.
Castilho, Marcelo Santos
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 123 : 639 - 648
[37] Discovery and Study of Novel Protein Tyrosine Phosphatase 1B Inhibitors
Zhang, Qian
Chen, Xi
Feng, Changgen
2ND INTERNATIONAL CONFERENCE ON MATERIALS SCIENCE, RESOURCE AND ENVIRONMENTAL ENGINEERING (MSREE 2017), 2017, 1890
[38] Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design
Fujimori, Ikuo
Wakabayashi, Takeshi
Murakami, Morio
Okabe, Atsutoshi
Ishii, Tsuyoshi
McGrath, Aaron
Zou, Hua
Saikatendu, Kumar Singh
Imoto, Hiroshi
ACS OMEGA, 2020, 5 (49): : 31984 - 32001
[39] A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors
Deniz, Utku
Ozkirimli, Elif
Ulgen, Kutlu O.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2016, 63 : 110 - 124
[40] Discovery of GSTZ1 as a novel target by using fully functionalized fragment-like probes and chemical proteomicsDiscovery
Liao, Yi
Chan, Sean Chin
Welsh, Eric
Fang, Bin
Koomen, John
Duckett, Derek
Haura, Eric
Monastyrskyi, Andrii
Rix, Uwe
MOLECULAR & CELLULAR PROTEOMICS, 2022, 21 (08) : S46 - S46

← 1 2 3 4 5 →